Taiwan permanently bans weight loss drug Belviq
Taipei, July 16 (CNA) The drug permit license for the weight loss drug Belviq has been permanently revoked in Taiwan, the country's Food and Drug Administration (FDA) said Thursday, citing cancer risks.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Taiwan's 'democratic values' will be factor in CPTPP entry evaluation: U.S.09/25/2021 01:01 PM
Taiwan headline news09/25/2021 11:56 AM
Voting gets underway for KMT chairman, party representative elections09/25/2021 08:37 AM
Taiwan court rules to allow trans woman's ID card gender change request09/24/2021 11:37 PM
Taiwan's police increase patrols after bomb threats to high-speed rail09/24/2021 11:00 PM